These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11472578)
21. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?]. Bień E; Balcerska A; Ciesielski D Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741 [TBL] [Abstract][Full Text] [Related]
22. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975 [TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597 [TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression. Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109 [TBL] [Abstract][Full Text] [Related]
25. Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma. Ristamäki R; Joensuu H; Lappalainen K; Teerenhovi L; Jalkanen S Blood; 1997 Nov; 90(10):4039-45. PubMed ID: 9354673 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas. Shah N; Cabanillas F; McIntyre B; Feng L; McLaughlin P; Rodriguez MA; Romaguera J; Younes A; Hagemeister FB; Kwak L; Fayad L Leuk Lymphoma; 2012 Jan; 53(1):50-6. PubMed ID: 21895545 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797 [TBL] [Abstract][Full Text] [Related]
28. [Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients]. Xia Y; Sun XF; Zhang CQ; Zhen ZJ; Wang ZH; Wang ZQ Ai Zheng; 2004 Nov; 23(11 Suppl):1448-50. PubMed ID: 15566654 [TBL] [Abstract][Full Text] [Related]
29. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A; Berg R Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [TBL] [Abstract][Full Text] [Related]
30. High prevelance of chronic magnesium deficiency in T cell lymphoblastic leukemia and chronic zinc deficiency in children with acute lymphoblastic leukemia and malignant lymphoma. Sahin G; Ertem U; Duru F; Birgen D; Yüksek N Leuk Lymphoma; 2000 Nov; 39(5-6):555-62. PubMed ID: 11342338 [TBL] [Abstract][Full Text] [Related]
31. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH; Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607 [TBL] [Abstract][Full Text] [Related]
32. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184 [TBL] [Abstract][Full Text] [Related]
33. Origin and function of circulating CD44 in non-Hodgkin's lymphoma. Ristämaki R; Joensuu H; Grön-Virta K; Salmi M; Jalkanen S J Immunol; 1997 Mar; 158(6):3000-8. PubMed ID: 9058839 [TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bureo E; Ortega JJ; Muñoz A; Cubells J; Madero L; Verdaguer A; Baro J; Olivé T; Maldonado MS; Pardo N Bone Marrow Transplant; 1995 Mar; 15(3):353-9. PubMed ID: 7599558 [TBL] [Abstract][Full Text] [Related]
35. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias. Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105 [TBL] [Abstract][Full Text] [Related]
36. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment. Beksaç M; Arat M; Akan H; Koç H; Ilhan O; Ozcan M Cancer; 2000 Oct; 89(7):1474-81. PubMed ID: 11013360 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression. Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787 [TBL] [Abstract][Full Text] [Related]
39. Malignant lymphomas in children in The Netherlands in the period 1973-1985: incidence in relation to leukemia: a report from the Dutch Childhood Leukemia Study Group. Coebergh JW; van der Does-van den Berg A; Kamps WA; Rammeloo JA; Valkenburg HA; van Wering ER Med Pediatr Oncol; 1991; 19(3):169-74. PubMed ID: 2023565 [TBL] [Abstract][Full Text] [Related]
40. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma. Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]